Search clinical trials for: Paricalcitol, Hydroxychloroquine, Losartan

Total 966 results

Patrick Hensley

Active, not recruiting

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Prostate Cancer Recurrent

United States
Sir Mortimer B. Davis - Jewish General Hospital

Withdrawn

Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women (HyPreC)

COVID-19 | Pregnant Women | SARS-CoV-2 | Hydroxychloroquine
First Affiliated Hospital Xi'an Jiaotong University

Completed

Efficacy Study of Hydroxychloroquine to Treat High-risk Coronary Artery Disease. (CHANGAN)

Coronary Artery Disease

China
King Abdullah International Medical Research Center

Completed

FAvipiravir and HydroxyChloroquine Combination Therapy (FACCT)

COVID19

Saudi Arabia
Assistance Publique - Hôpitaux de Paris

Withdrawn

Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients (MG-COVID)

Covid-19
Abramson Cancer Center of the University of Pennsylvania

Completed

Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Universitaire Ziekenhuizen KU Leuven

Unknown

Effect of Bitter in Overweight Female Volunteers (PLAQOW)

Obesity
ScandiBio Therapeutics AB
Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Kanuni Sultan Suleyman... and other collaborators

Unknown

Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients

COVID-19

Turkey
Medical University of South Carolina

Recruiting

COAST Therapy in Advanced Solid Tumors and Prostate Cancer (COAST)

Prostate Cancer Recurrent | Solid Tumor, Adult

United States
Universidade do Vale do Sapucai
Pfizer; Apsen Farmaceutica S.A.; Biofarma; Dermadia; Methodos Laboratory

Completed

Prevention of Complications (SARS-CoV-2): Clinical Study

Complication

Brazil
Coordinación de Investigación en Salud, Mexico
Ultra Laboratorios SA. de CV.

Recruiting

Hidroxicloroquina With Azitromicina Versus Hidroxicloroquina and Placebo Int Patients With Mild COVID-19 (Omehecatl)

Covid19

Mexico
University of Malaga
Carlos III Health Institute; Instituto de Investigacion Biomedica de Malaga

Unknown

Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM) (PREVICHARM)

Coronavirus Infection | Sars-CoV2 | Prevention & Control | Nursing Home | Hydroxychloroquine
Shaheed Zulfiqar Ali Bhutto Medical University

Unknown

Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 (CHEER)

COVID 19

Pakistan
Universitaire Ziekenhuizen KU Leuven

Unknown

Effect of Hydroxychloroquine Sulphate in Healthy Lean Females (PLAQHV)

Obesity
Steadman Philippon Research Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Active, not recruiting

Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

Osteoarthritis, Knee

United States
Sheba Medical Center

Unknown

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus (COSTA)

COVID - 19

Israel
Organon and Co

Completed

Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)

Hypertension
Hennepin Healthcare Research Institute

Completed

Losartan to Reduce Inflammation and Fibrosis Endpoints in HIV Trial (LIFE-HIV)

Fibrosis | Inflammation

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Merck Sharp & Dohme LLC

Completed

MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension

Hypertension
Organon and Co

Completed

Obese Hypertension Study (0954-315)

Hypertension
Pharmtechnology LLC
Reliance Life Sciences Private Limited

Completed

A Bioequivalence Study of Losartan Potassium Tablets (Containing Losartan Potassium 100 mg) in Normal, Healthy, Adults Under Fasting Conditions

Healthy

India
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Healthy

Canada
University of Alberta

Completed

IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT (IMPACT)

Rheumatoid Arthritis | Psoriatic Arthritis | Covid-19 Infection | Hydroxychloroquine

Canada
Abderrahmane Mami Hospital
Eshmoun Clinical Research Center; Datametrix

Withdrawn

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals (COVID_2Pro)

COVID19 | Sars-CoV2 | Prophylaxis | Hydroxychloroquine | Healthcare Worker

Tunisia
Iterum Therapeutics, International Limited
Waterbury Hospital

Withdrawn

Azithromycin Plus Hydroxychloroquine for COVID-19 Infection

Respiratory Tract Infection Viral

United States
Hospital Israelita Albert Einstein
Hospital do Coracao; Hospital Sirio-Libanes; Brazilian Research In Intensive... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II)

Coronavirus Infections | Pneumonia, Viral

Brazil
Centre Hospitalier Universitaire de Saint Etienne
CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang

Terminated

Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients (PREAVIS)

Sars-CoV2

France
H. Lee Moffitt Cancer Center and Research Institute
Novartis Pharmaceuticals

Recruiting

Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA

Myelodysplastic Syndromes

United States
University of Cambridge
British Heart Foundation

Unknown

Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension (Pathway 1)

Essential Hypertension | Hypertension, Resistant to Conventional Therapy

United Kingdom
Zealand University Hospital

Terminated

Treatment of Secondary Hyperparathyroidism in the Uremic Patient

Vitamin D Deficiency | Chronic Kidney Disease | Secondary Hyperparathyroidism

Denmark
Medical College of Wisconsin

Withdrawn

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

Advanced Breast Cancer | Solid Tumor

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

Chronic Kidney Disease

Korea, Republic of
Mansoura University

Completed

The Effect of Losartan on the Recoverability of Renal Function in Anuric and Oliguric Patients With Unilateral Obstructed Kidney

Uropathy | Losartan Adverse Reaction | Uropathy Obstructive

Egypt
Newcastle-upon-Tyne Hospitals NHS Trust
Newcastle University

Completed

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study (FELINE)

Nonalcoholic Steatohepatitis

United Kingdom
Assaf-Harofeh Medical Center

Unknown

Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?

Hypertension
Pamukkale University
Gazi University

Completed

Investigation of MDR1 Gene Polymorphism and Losartan Plasma Concentration in Patients Undergoing Hypertensive Episodes While Under Losartan Treatment

Hypertension

Turkey
Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Healthy

Czech Republic
Steadman Philippon Research Institute
United States Department of Defense; Office of Naval Research (ONR)

Terminated

Losartan to Improve Hip Microfracture

Fibrosis | Hip Osteoarthritis | Cartilage Damage | Hip Impingement Syndrome

United States
Azidus Brasil

Suspended

Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19

Covid-19

Brazil
Rutgers, The State University of New Jersey

Withdrawn

Asymptomatic COVID-19 Trial (ACT)

SARS-CoV-2 Infection

United States
Latin American Cooperative Oncology Group
Oncoclínicas

Withdrawn

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (HOPE_BRAZIL)

Sars-CoV2

Brazil
Tanta University

Unknown

Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19

COVID-19
National University Hospital, Singapore
Massachusetts General Hospital; AstraZeneca

Unknown

Hydroxychloroquine and Gefitinib to Treat Lung Cancer

Non-small Cell Lung Cancer

Singapore
Brigham and Women's Hospital
Merck Sharp & Dohme LLC

Completed

A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients

Hyperglycemia | Hypertension | Obesity

United States
Boryung Pharmaceutical Co., Ltd
Chonbuk National University Hospital; Samsung Medical Center; Asan Medical Center and other collaborators

Completed

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

Hypertension
Ain Shams University

Recruiting

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Colorectal Cancer | Chemotherapy | Oral Mucositis | Intestinal Mucositis

Egypt
Miriam Vos, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Children...

Completed

Study of Losartan in the Treatment of NAFLD in Children

NAFLD

United States
Organon and Co

Completed

MK0954A-264 Filter Study (0954A-264)(COMPLETED)

Mild to Severe Hypertension
Hanmi Pharmaceutical Company Limited

Completed

A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan

Healthy

Czech Republic

Search clinical trials for: Paricalcitol, Hydroxychloroquine, Losartan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations